Literature DB >> 24813157

Succinate dehydrogenase subunit D and succinate dehydrogenase subunit B mutation analysis in canine phaeochromocytoma and paraganglioma.

D E Holt1, P Henthorn2, V M Howell3, B G Robinson4, D E Benn4.   

Abstract

Phaeochromocytomas (PCs) are tumours of the adrenal medulla chromaffin cells. Paragangliomas (PGLs) arise in sympathetic ganglia (previously called extra-adrenal PCs) or in non-chromaffin parasympathetic ganglia cells that are usually non-secretory. Parenchymal cells from these tumours have a common embryological origin from neural crest ectoderm. Several case series of canine PCs and PGLs have been published and a link between the increased incidence of chemoreceptor neoplasia in brachycephalic dog breeds and chronic hypoxia has been postulated. A similar link to hypoxia in man led to the identification of germline heterozygous mutations in the gene encoding succinate dehydrogenase subunit D (SDHD) and subsequently SDHA, SDHB and SDHC in similar tumours. We investigated canine PCs (n = 6) and PGLs (n = 2) for SDHD and SDHB mutations and in one PGL found a somatic SDHD mutation c.365A>G (p.Lys122Arg) in exon 4, which was not present in normal tissue from this brachycephalic dog. Two PCs were heterozygous for both c.365A>G (p.Lys122Arg) mutation and an exon 3 silent variant c.291G>A. We also identified the heterozygous SDHB exon 2 mutation c.113G>A (p.Arg38Gln) in a PC. These results illustrate that genetic mutations may underlie tumourigenesis in canine PCs and PGLs. The spontaneous nature of these canine diseases and possible association of PGLs with hypoxia in brachycephalic breeds may make them an attractive model for studying the corresponding human tumours.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  SDHD/B gene; dog; paraganglioma; phaeochromocytoma

Mesh:

Substances:

Year:  2014        PMID: 24813157     DOI: 10.1016/j.jcpa.2014.03.007

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  5 in total

1.  Primary thyroid paraganglioma mimicking medullary thyroid carcinoma: A case report.

Authors:  Xing Yu; Yong Wang; Ping Wang; Cai-Hong Ji; Chun-DI Miao; Shu Zheng
Journal:  Oncol Lett       Date:  2015-05-28       Impact factor: 2.967

2.  Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017).

Authors:  Margaret L Musser; Kathryn L Taikowski; Chad M Johannes; Philip J Bergman
Journal:  BMC Vet Res       Date:  2018-09-03       Impact factor: 2.741

3.  A First Case Report of Orbital Extra-Adrenal Paraganglioma in Cat.

Authors:  Leonardo Leonardi; Raluca Ioana Rizac; Ilaria Pettinari; Luca Mechelli; Carlo De Feo
Journal:  Vet Sci       Date:  2021-05-14

4.  Molecular Alterations in Dog Pheochromocytomas and Paragangliomas.

Authors:  Esther Korpershoek; Daphne A E R Dieduksman; Guy C M Grinwis; Michael J Day; Claudia E Reusch; Monika Hilbe; Federico Fracassi; Niels M G Krol; André G Uitterlinden; Annelies de Klein; Bert Eussen; Hans Stoop; Ronald R de Krijger; Sara Galac; Winand N M Dinjens
Journal:  Cancers (Basel)       Date:  2019-04-30       Impact factor: 6.639

Review 5.  Model systems in SDHx-related pheochromocytoma/paraganglioma.

Authors:  Krisztina Takács-Vellai; Zsolt Farkas; Fanni Ősz; Gordon W Stewart
Journal:  Cancer Metastasis Rev       Date:  2021-12-27       Impact factor: 9.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.